The present disclosure provides a compound of Formula (I' ) : (I' ) or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein Ra, Rb, Rx, Ri, R2, X2, and q are as defined herein, methods of making and its use in the treatment of a disorder or disease associated with the reduction of IKZF2 protein levels.